• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于基因治疗测试的全器官肝脏工程

An Whole-Organ Liver Engineering for Testing of Genetic Therapies.

作者信息

Lorvellec Maëlle, Pellegata Alessandro Filippo, Maestri Alice, Turchetta Chiara, Alvarez Mediavilla Elena, Shibuya Soichi, Jones Brendan, Scottoni Federico, Perocheau Dany P, Cozmescu Andrei Claudiu, Delhove Juliette M, Kysh Daniel, Gjinovci Asllan, Counsell John R, Heywood Wendy E, Mills Kevin, McKay Tristan R, De Coppi Paolo, Gissen Paul

机构信息

MRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, UK.

Genetics and Genomic Medicine Department, Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.

出版信息

iScience. 2020 Nov 13;23(12):101808. doi: 10.1016/j.isci.2020.101808. eCollection 2020 Dec 18.

DOI:10.1016/j.isci.2020.101808
PMID:33305175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7708813/
Abstract

Explosion of gene therapy approaches for treating rare monogenic and common liver disorders created an urgent need for disease models able to replicate human liver cellular environment. Available models lack 3D liver structure or are unable to survive in long-term culture. We aimed to generate and test a 3D culture system that allows long-term maintenance of human liver cell characteristics. The whole-organ "Bioreactor grown Artificial Liver Model" (BALM) employs a custom-designed bioreactor for long-term 3D culture of human induced pluripotent stem cells-derived hepatocyte-like cells (hiHEPs) in a mouse decellularized liver scaffold. Adeno-associated viral (AAV) and lentiviral (LV) vectors were introduced by intravascular injection. Substantial AAV and LV transgene expression in the BALM-grown hiHEPs was detected. Measurement of secreted proteins in the media allowed non-invasive monitoring of the system. We demonstrated that humanized whole-organ BALM is a valuable tool to generate pre-clinical data for investigational medicinal products.

摘要

用于治疗罕见单基因和常见肝脏疾病的基因治疗方法激增,迫切需要能够复制人类肝脏细胞环境的疾病模型。现有的模型缺乏三维肝脏结构,或者无法在长期培养中存活。我们旨在生成并测试一种能够长期维持人类肝脏细胞特征的三维培养系统。全器官“生物反应器培养人工肝模型”(BALM)采用定制设计的生物反应器,用于在小鼠脱细胞肝脏支架中对人诱导多能干细胞来源的肝细胞样细胞(hiHEP)进行长期三维培养。通过血管内注射引入腺相关病毒(AAV)和慢病毒(LV)载体。在BALM培养的hiHEP中检测到大量AAV和LV转基因表达。通过测量培养基中的分泌蛋白可以对该系统进行非侵入性监测。我们证明,人源化全器官BALM是为研究性药品生成临床前数据的宝贵工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/7708813/637022308722/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/7708813/91218307e32a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/7708813/3a9bfa28cfa6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/7708813/e4d436ca9ee0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/7708813/b9875ae66a5c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/7708813/637022308722/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/7708813/91218307e32a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/7708813/3a9bfa28cfa6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/7708813/e4d436ca9ee0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/7708813/b9875ae66a5c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/7708813/637022308722/gr4.jpg

相似文献

1
An Whole-Organ Liver Engineering for Testing of Genetic Therapies.用于基因治疗测试的全器官肝脏工程
iScience. 2020 Nov 13;23(12):101808. doi: 10.1016/j.isci.2020.101808. eCollection 2020 Dec 18.
2
A Perfusion Bioreactor for Longitudinal Monitoring of Bioengineered Liver Constructs.一种用于对生物工程肝脏构建体进行纵向监测的灌注生物反应器。
Nanomaterials (Basel). 2021 Jan 21;11(2):275. doi: 10.3390/nano11020275.
3
Rat liver extracellular matrix and perfusion bioreactor culture promote human amnion epithelial cell differentiation towards hepatocyte-like cells.大鼠肝脏细胞外基质和灌注生物反应器培养促进人羊膜上皮细胞向肝细胞样细胞分化。
J Tissue Eng. 2023 Dec 22;14:20417314231219813. doi: 10.1177/20417314231219813. eCollection 2023 Jan-Dec.
4
scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution.scAAVengr,一种基于转录组的用于单细胞分辨率定量排序工程化 AAV 的工具。
Elife. 2021 Oct 19;10:e64175. doi: 10.7554/eLife.64175.
5
Expansion of Transdifferentiated Human Hepatocytes in a Serum-Free Microcarrier Culture System.人源肝干细胞在无血清微载体培养系统中的扩增。
Dig Dis Sci. 2020 Jul;65(7):2009-2023. doi: 10.1007/s10620-019-05925-8. Epub 2019 Nov 13.
6
Pluripotent stem cell-derived bile canaliculi-forming hepatocytes to study genetic liver diseases involving hepatocyte polarity.多能干细胞衍生的胆小管形成肝细胞用于研究涉及肝细胞极性的遗传性肝脏疾病。
J Hepatol. 2019 Aug;71(2):344-356. doi: 10.1016/j.jhep.2019.03.031. Epub 2019 Apr 6.
7
Macrophage Inhibitor Clodronate Enhances Liver Transduction of Lentiviral but Not Adeno-Associated Viral Vectors or mRNA Lipid Nanoparticles in Neonatal and Juvenile Mice.巨噬细胞抑制剂氯膦酸盐增强新生和幼年小鼠慢病毒而非腺相关病毒载体或 mRNA 脂质纳米颗粒的肝脏转导。
Cells. 2024 Nov 29;13(23):1979. doi: 10.3390/cells13231979.
8
3D scaffold-free microlivers with drug metabolic function generated by lineage-reprogrammed hepatocytes from human fibroblasts.由人成纤维细胞重编程的肝系细胞生成具有药物代谢功能的 3D 无支架微肝。
Biomaterials. 2021 Feb;269:120668. doi: 10.1016/j.biomaterials.2021.120668. Epub 2021 Jan 8.
9
Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments.细胞外基质中诱导多能干细胞来源肝细胞的功能成熟——生物人工肝微环境的比较分析
Stem Cells Transl Med. 2016 Sep;5(9):1257-67. doi: 10.5966/sctm.2015-0235. Epub 2016 Jul 15.
10
Three-dimensional multipotent progenitor cell aggregates for expansion, osteogenic differentiation and 'in vivo' tracing with AAV vector serotype 6.三维多能祖细胞聚集体用于扩增、成骨分化和 AAV 载体血清型 6 的“体内”示踪。
Gene Ther. 2013 Feb;20(2):158-68. doi: 10.1038/gt.2012.16. Epub 2012 Mar 8.

引用本文的文献

1
Machine Perfusion and Bioengineering Strategies in Transplantation-Beyond the Emerging Concepts.机器灌注和移植中的生物工程策略——超越新兴概念。
Transpl Int. 2024 Aug 29;37:13215. doi: 10.3389/ti.2024.13215. eCollection 2024.
2
precision-cut liver slices model disease phenotype and monitor therapeutic response for liver monogenic diseases.精密肝切片模型可模拟肝脏单基因疾病的疾病表型并监测治疗反应。
F1000Res. 2024 Apr 8;12:1580. doi: 10.12688/f1000research.142014.2. eCollection 2023.
3
Decellularized extracellular matrix materials for treatment of ischemic cardiomyopathy.

本文引用的文献

1
Engineering liver microtissues for disease modeling and regenerative medicine.用于疾病建模和再生医学的工程化肝脏微组织
Adv Funct Mater. 2020 Oct 28;30(44). doi: 10.1002/adfm.201909553. Epub 2020 Feb 19.
2
Assembly and Function of a Bioengineered Human Liver for Transplantation Generated Solely from Induced Pluripotent Stem Cells.生物工程化人肝用于移植的组装和功能,其细胞完全来源于诱导多能干细胞。
Cell Rep. 2020 Jun 2;31(9):107711. doi: 10.1016/j.celrep.2020.107711.
3
Pediatric Cholestatic Liver Disease: Review of Bile Acid Metabolism and Discussion of Current and Emerging Therapies.
用于治疗缺血性心肌病的脱细胞细胞外基质材料
Bioact Mater. 2023 Nov 29;33:460-482. doi: 10.1016/j.bioactmat.2023.10.015. eCollection 2024 Mar.
4
Lessons learned from pre-clinical testing of xenogeneic decellularized esophagi in a rabbit model.从兔模型中异种脱细胞食管的临床前测试中学到的经验教训。
iScience. 2022 Sep 22;25(10):105174. doi: 10.1016/j.isci.2022.105174. eCollection 2022 Oct 21.
5
Modelling urea cycle disorders using iPSCs.利用诱导多能干细胞模拟尿素循环障碍。
NPJ Regen Med. 2022 Sep 26;7(1):56. doi: 10.1038/s41536-022-00252-5.
6
Recent Advances in Liver Engineering With Decellularized Scaffold.脱细胞支架在肝脏工程中的最新进展
Front Bioeng Biotechnol. 2022 Feb 10;10:831477. doi: 10.3389/fbioe.2022.831477. eCollection 2022.
7
A Perfusion Bioreactor for Longitudinal Monitoring of Bioengineered Liver Constructs.一种用于对生物工程肝脏构建体进行纵向监测的灌注生物反应器。
Nanomaterials (Basel). 2021 Jan 21;11(2):275. doi: 10.3390/nano11020275.
小儿胆汁淤积性肝病:胆汁酸代谢综述及当前和新兴治疗方法的讨论
Front Med (Lausanne). 2020 May 5;7:149. doi: 10.3389/fmed.2020.00149. eCollection 2020.
4
Next-Generation Liver Medicine Using Organoid Models.利用类器官模型的新一代肝脏医学
Front Cell Dev Biol. 2019 Dec 20;7:345. doi: 10.3389/fcell.2019.00345. eCollection 2019.
5
Genetic-Based Approaches to Inherited Metabolic Liver Diseases.基于遗传的遗传性代谢性肝病治疗方法。
Hum Gene Ther. 2019 Oct;30(10):1190-1203. doi: 10.1089/hum.2019.140.
6
Human organotypic bioconstructs from organ-on-chip devices for human-predictive biological insights on drug candidates.用于药物候选物的人体预测性生物学见解的器官芯片设备中的人体器官型生物构建体。
Expert Opin Drug Saf. 2019 Aug;18(8):651-677. doi: 10.1080/14740338.2019.1634689. Epub 2019 Jul 3.
7
Challenges and Opportunities in the Design of Liver-on-Chip Microdevices.在肝芯片微器件设计中的挑战和机遇。
Annu Rev Biomed Eng. 2019 Jun 4;21:219-239. doi: 10.1146/annurev-bioeng-060418-052305.
8
Oxysterols and nuclear receptors.氧化固醇与核受体
Mol Cell Endocrinol. 2019 Mar 15;484:42-51. doi: 10.1016/j.mce.2019.01.016. Epub 2019 Jan 18.
9
Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail.临床前动物研究中的外部有效性问题能否克服?为什么大多数动物模型注定会失败。
J Transl Med. 2018 Nov 7;16(1):304. doi: 10.1186/s12967-018-1678-1.
10
Lessons learned from lung and liver in-vivo gene therapy: implications for the future.从肺和肝的体内基因治疗中吸取的教训:对未来的启示。
Expert Opin Biol Ther. 2018 Sep;18(9):959-972. doi: 10.1080/14712598.2018.1506761. Epub 2018 Aug 10.